IBRX - SHAREHOLDER ALERT: Levi & Korsinsky Notifies ImmunityBio Inc. (IBRX) Investors of a Class Action Lawsuit and Upcoming Deadline | Benzinga

NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ImmunityBio, Inc. ("ImmunityBio" or the "Company") (NASDAQ:IBRX) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ImmunityBio investors who were adversely affected by alleged securities fraud between May 23, 2022 and May 10, 2023. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/immunitybio-lawsuit-submission-form?prid=44789&wire=3

IBRX investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) ImmunityBio conducted insufficient due diligence to discover, or else did discover and ignored, ...

IBRX) Investors of a Class Action Lawsuit and Upcoming Deadline>Full story available on Benzinga.com